Clinical Trials
35
Active:0
Completed:14
Trial Phases
4 Phases
Phase 1:1
Phase 3:9
Phase 4:2
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (22 trials with phase data)• Click on a phase to view related trials
Not Applicable
10 (45.5%)Phase 3
9 (40.9%)Phase 4
2 (9.1%)Phase 1
1 (4.5%)Safety and Efficacy of Pulmonary Vein Isolation Using Pulsed-field Ablation (PFA) Combined with Either PFA-based Left Atrial Posterior Wall Isolation or Vein of Marshall Ethanol Ablation in Patients with Persistent Atrial Fibrillation
Not yet recruiting
- Conditions
- Atrial Fibrillation (AF)
- First Posted Date
- 2025-03-17
- Last Posted Date
- 2025-03-17
- Lead Sponsor
- Texas Cardiac Arrhythmia Research Foundation
- Target Recruit Count
- 162
- Registration Number
- NCT06878924
Safety and Efficacy of Pulsed-field Ablation for Atrial Fibrillation in High Versus Low-volume Ablation Centers (SAFFICIENT)
Terminated
- Conditions
- Atrial Fibrillation
- First Posted Date
- 2024-07-05
- Last Posted Date
- 2025-05-28
- Lead Sponsor
- Texas Cardiac Arrhythmia Research Foundation
- Target Recruit Count
- 75
- Registration Number
- NCT06488820
- Locations
- 🇺🇸
Texas Cardiac Arrhythmia, Austin, Texas, United States
Post-ablation Alcohol Impacts Arrhythmia Recurrence, Quality of Life and Cognition in AF
Not Applicable
Not yet recruiting
- Conditions
- Atrial Fibrillation
- First Posted Date
- 2022-08-22
- Last Posted Date
- 2022-08-22
- Lead Sponsor
- Texas Cardiac Arrhythmia Research Foundation
- Target Recruit Count
- 130
- Registration Number
- NCT05510167
Natural History of COVID-19-Related Atrial Fibrillation
Not Applicable
- Conditions
- COVID-19Atrial Fibrillation New Onset
- First Posted Date
- 2021-04-05
- Last Posted Date
- 2021-11-23
- Lead Sponsor
- Texas Cardiac Arrhythmia Research Foundation
- Target Recruit Count
- 200
- Registration Number
- NCT04830774
- Locations
- 🇺🇸
Kansas City Heart Rhythm Institute, Overland Park, Kansas City, Kansas, United States
🇺🇸Texas Cardiac Arrhythmia Institute, Austin, Texas, United States
🇧🇪Vrije Universiteit Brussel, Brussel, Belgium
Immune Response Following COVID-19 Vaccination
- Conditions
- IgM and IgG in Blood
- First Posted Date
- 2021-02-03
- Last Posted Date
- 2021-02-03
- Lead Sponsor
- Texas Cardiac Arrhythmia Research Foundation
- Target Recruit Count
- 500
- Registration Number
- NCT04736524
- Locations
- 🇺🇸
Texas Cardiac arrhythmia Institute, St. David's Hospital, Austin, Texas, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- Next
News
No news found